Mineralys Therapeutics Insider Trades

MLYS

Track insider trading activity from Mineralys Therapeutics executives and directors. See which insiders are buying and selling MLYS stock.

Trades Last 12 Months

All Insider Trades for Mineralys Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Rodman David Malcom Chief Medical Officer
Holding Value $1.6M 63,860 shares
Last Trade
May 18, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$11k 417 shares
$26.39
$25.06
Congleton Jon Chief Executive Officer
Holding Value $17.3M 689,321 shares
Last Trade
Apr 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$422k 15,730 shares
$26.83
$25.06
Karydas Daphne Director
Holding Value $231k 9,200 shares
Last Trade
Mar 31, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$81.3k 3,000 shares
$27.09
$25.06
Holding Value $146M 5,825,521 shares
Last Trade
Mar 30, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.41M 58,300 shares
$24.16
$25.06
Warren Eric Chief Commercial Officer
Holding Value $962k 38,400 shares
Last Trade
Mar 04, 2026 Sale
$11.7M 408,300 shares
$28.77
$25.06
Akkaraju Srinivas 10% owner
Holding Value $155k 6,200 shares
Last Trade
Feb 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$174k 6,200 shares
$28.06
$25.06
Di Rocco Derek Director
Holding Value $155k 6,200 shares
Last Trade
Feb 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$174k 6,200 shares
$28.06
$25.06
Gold Alexander M Director
Holding Value $208k 8,300 shares
Last Trade
Feb 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$407k 14,500 shares
$28.06
$25.06
Levy Adam Scott CFO And Secretary
Holding Value $1.34M 53,300 shares
Last Trade
Feb 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.62M 93,200 shares
$28.06
$25.06
Sblendorio Glenn Director
Holding Value $155k 6,200 shares
Last Trade
Feb 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$174k 6,200 shares
$28.06
$25.06
Holding Value $198M 7,910,038 shares
Last Trade
Feb 19, 2026 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$407k 14,500 shares
$28.06
$25.06
Holding Value $142M 5,674,916 shares
Last Trade
Mar 13, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.1M 600,000 shares
$13.50
$25.06
Dirocco Derek Director
Holding Value $824k 32,900 shares
Last Trade
Feb 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$336k 32,900 shares
$10.20
$25.06
Litzka Olivier Director
Holding Value $551k 22,000 shares
Last Trade
May 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$275k 22,000 shares
$12.52
$25.06
Holding Value $0 0 shares
Last Trade
Jul 12, 2023 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$704k 44,000 shares
$16.00
$25.06
Holding Value $48.7M 1,941,368 shares
Last Trade
Feb 14, 2023 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$35M 1,941,368 shares
$18.01
$25.06

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up